نتائج البحث

Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)

• Source: Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/

تفاصيل العنوان

Pomalidomide in Treating Patients With Relapsed or Refractory Waldenstrom Macroglobulinemia

• Authors : National Cancer Institute (NCI)

• Source: Phase I Study of Pomalidomide in Relapsed or Refractory Waldenstrom Macroglobulinemia

تفاصيل العنوان

Study of Iopofosine I 131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) and Pivotal Expansion in Waldenstrom Macroglobulinemia (CLOVER-WaM)

• Source: An Open-Label, Multicenter, Phase 2 Study of Iopofosine I 131 (CLR 131) in Patients With Relapsed or Refractory (R/R) Select B-Cell Malignancies (CLOVER-1) and Expansion Cohort in Patients With

تفاصيل العنوان

Ibrutinib and Ixazomib Citrate in Treating Newly Diagnosed, Relapsed or Refractory Waldenstrom Macroglobulinemia

• Source: Phase II Study of Ibrutinib in Combination With Ixazomib in Patients With Waldenström Macroglobulinemia

تفاصيل العنوان

Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related Disorders

• Authors : Irene Ghobrial, MD, Principal Investigator

• Source: Medical Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related Disorders

تفاصيل العنوان

A Study of ICP-022 in the Treatment of Recurrent or Refractory Waldenstrom Macroglobulinemia

• Source: A Multicenter, Open Clinical Trial to Evaluate the Safety and Efficacy of ICP-022 in the Treatment of Recurrent or Refractory Waldenstrom

تفاصيل العنوان

A Phase II Study to Evaluate the Efficacy of Bortezomib in Combination with Thalidomide in Treatment-Naïve Waldenstrom Macroglobulinemia Patients.

• Authors : Byun JM; Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.; Shin J

Subjects: Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/adverse effects ; Waldenstrom Macroglobulinemia*/Waldenstrom Macroglobulinemia*/Waldenstrom Macroglobulinemia*/drug therapy; Humans

• Source: Cancer research and treatment [Cancer Res Treat] 2024 Apr; Vol. 56 (2), pp. 675-680. Date of Electronic Publication: 2023 Sep 25.Publisher: The Association Country of Publication: Korea (South) NLM ID: 101155137 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Clinical characteristic and outcome of lymphoplasmacytic lymphoma of non-Waldenstrom macroglobulinemia type: A Swedish lymphoma registry study

• Authors : Brandefors, L; Sander, B; Lundqvist, K

Subjects: Medicin och hälsovetenskap

• Source: British journal of haematology. 196(6):1362-1368

تفاصيل العنوان

Waldenstrom Macroglobulinemia Recurrence with Bing–Neel Syndrome Presentation.

• Authors : Capasso, Raffaella¹ (AUTHOR) ; Buonincontro, Miriam² (AUTHOR) ; Caranci, Ferdinando³ (AUTHOR)

• Source: Reports (MDPI AG). Jun2024, Vol. 7 Issue 2, p34. 7p.

تفاصيل العنوان

Sustained Response of Ibrutinib in a Patient with Waldenstrom Macroglobulinemia Presenting with Myasthenic Crisis as a Paraneoplastic Neurological Syndrome: A Case Report and Review of Literature

• Authors : Anna Mira Lubis; Fitri Octaviana; Gabriella Anindyah

Subjects: paraneoplastic; myasthenia gravis; ibrutinib

• Source: Acta Medica Indonesiana, Vol 56, Iss 2 (2024)

تفاصيل العنوان